Introduction 87
The ability to make adaptive choices requires multiple cognitive operations that work in 88 concert to guide efficient and optimal behavior (Rangel et al., 2008) . For example, an organism 89 must calculate the objective and subjective value of the available options, which entails evaluating 90 the relative value of both the benefits and costs associated with each option. This information 91 must be acquired from past experience, such as the contingencies of previous actions and their 92 outcomes, as well as other motivational (e.g., hunger) and environmental (e.g. presence of salient 93 predictive cues) factors. Finally, the organism must determine the value of the actual outcome of 94 its choice, and use this information as feedback to guide future choices. Together, these 95 processes allow an organism to execute or inhibit its choice behavior as appropriate to its past, 96 current, and anticipated future conditions. While the majority of individuals are able to effectively 97 engage these processes and make adaptive decisions, individuals with psychiatric diseases such 98 as substance use disorder, anorexia nervosa, and post-traumatic stress disorder exhibit impaired 99 decision making (Bechara and Damasio, 2002; Crowley et al., 2010; Najavits et al., 2011; 100 decision making (Crowley et al., 2010; Gowin et al., 2013) . More recently, the BLA has been 113 implicated in decision making involving risk of explicit punishment (Orsini et al., 2015a) . In well-114 trained rats, BLA lesions increased choice of a large reward associated with risk of footshock 115 punishment. These data suggested that the BLA is critical for the integration of reward-and 116 punishment-related information to guide optimal behavior. Importantly, however, it is unclear how 117 and at what point in the decision-making process this integration occurs. 118
In vivo electrophysiological studies show that BLA neurons do not respond uniformly to 119 salient stimuli but instead mediate different aspects of motivated behavior. For example, different 120 populations of BLA neurons respond differentially to rewarding and aversive outcomes 121 (Schoenbaum et al., 1998 (Schoenbaum et al., , 1999 Paton et al., 2006; Belova et al., 2007; Belova et al., 2008; 122 Shabel and Janak, 2009; Sangha et al., 2013; Gore et al., 2015) , and are organized into 123
intrinsically (Zhang et al., 2013) and extrinsically distinct circuits Beyeler et 124 al., 2016) . In addition, amygdala neurons differentially contribute to generation of prospective 125 plans to obtain immediate rewards (Grabenhorst et al., 2012) as well as rewards in the distant 126 future (Hernadi et al., 2015) . This functional heterogeneity within the BLA supports the hypothesis 127 that the BLA is differentially engaged during decision making involving rewarding and aversive 128 outcomes. How the BLA is recruited, however, may depend on the specific cognitive components 129
Subjects 139
Male Long-Evans rats (weighing 250-275 g upon arrival; Charles River Laboratories, 140 Raleigh, NC) were individually housed and kept on a 12 h light/dark cycle with free access to food 141 and water except as indicated below. Upon arrival, rats were handled daily for one week prior to 142 undergoing surgery. During behavioral testing, rats were maintained at 90% of their free-feeding 143 weight, with their target weights adjusted upward by 5 g/week to account for growth. Animal 144 procedures were conducted in accordance with the University of Florida Institutional Animal Care 145 and Use Committee and followed guidelines of the National Institutes of Health. 146
Apparatus 147
Behavioral testing was conducted in three computer-controlled operant test chambers 148 (Coulbourn Instruments), each of which was contained in a sound-attenuating cabinet. Chambers 149 were equipped with a centrally located food trough (TAMIC Instruments) that projected 3 cm into 150 the chamber and contained a photobeam to detect trough entries. The trough was connected to 151 a feeder, from which 45 mg food pellets (Test Diet, AIN-76A, 5TUL) were delivered into the trough. 152 A nosepoke hole was located above the food trough and two retractable levers were positioned 153 to the left and right of the trough, 11 cm above the floor of the chamber. A 1.12 W lamp was 154 positioned on the back wall of the sound-attenuating cabinet, and served as a houselight. The 155 floor of the test chamber was comprised of stainless steel rods connected to a shock generator 156 that delivered scrambled footshocks. Each operant test chamber was interfaced with a computer (eNpHR3.0 group) or mCherry (control group) in the BLA. To reach the brain, light was passed 163 from the laser through a patch cord (200 µm core, Thor Labs), a rotary joint (1 X 2, 200 µm core, 164 Doric Lenses) located above the operant chamber, 2 additional patch cords (200 µm core, 0.22 165 NA, Thor Labs) and bilateral optic fibers (200 µm core, 0.22 NA, 8.3 mm in length; Precision Fiber 166 Products) implanted in the BLA. The laser was interfaced with the computer running Graphic State 167 4.0 software to allow for precise timing of light delivery during different task phases. 168
Surgical procedures 169
Rats were anesthetized with isoflurane gas (1-5% in O2) and received subcutaneous 170 injections of meloxicam (2 mg/kg), buprenorphine (0.05 mg/kg), and sterile saline (10 mL). Rats 171 were placed into a stereotaxic apparatus (David Kopf) and the scalp was cleaned with a 172 chlorohexidine/isopropyl alcohol swab. A sterile adhesive surgical drape was subsequently 173 placed over the body. 174
For rats used in in vitro electrophysiology experiments, the scalp was incised and retracted 175 and the skull was leveled to ensure that bregma and lambda were in the same horizontal plane. 176
Two burr holes were drilled for bilateral virus injections into the BLA (AP: -3.2, ML: ±4.9, DV: -8.5, 177 -8.1 mm from skull surface). At each site, an injection needle was lowered to the target depth and 178 AAV5-CAMKIIα-eHpNR3.0-mCherry (University of North Carolina Vector Core) was infused into 179 the BLA (0.4 µl at the ventral DV coordinate and 0.2 µl at the dorsal DV coordinate, at a rate of 180 0.5 µl/min). The injection needle was attached to polyethylene tubing, which was connected to a 181 10 µl Hamilton syringe mounted on a syringe pump (Harvard Apparatus). After each injection, the 182 needle was left in place for an additional 5 minutes to allow for diffusion of the virus. The incision 183 was then sutured and rats were given an additional 10 mL of saline before being placed on a 184 heating pad to recover from surgery. 185
For rats used in behavioral experiments, the scalp was incised and retracted and six small 186 burr holes were drilled into the skull for placement of jeweler's screws. Two screws were placed 187 anterior to bregma, two between bregma and lambda and two posterior to lambda. This 188 configuration was used to ensure that the headcap was secured evenly across the skull surface. 189
After leveling the skull to ensure that bregma and lambda were in the same horizontal plane, two 190 additional burr holes were drilled for bilateral implantation of guide cannulae (22 gauge; Plastics 191 One) above the BLA (AP: -3.3, ML: ±4.9, DV: -7.3 from skull surface). Dental cement was used 192 to anchor the cannulae in place. Once the dental cement was set, an injection needle was lowered 193 into each cannula (the tip of the injection needle extended 1.5 mm beyond the end of the cannula) 194 and AAV5-CAMKIIα-eHpNR3.0-mCherry or AAV5-CAMKIIα-mCherry (University of North 195 Carolina Vector Core) was infused into the BLA (0.6 µl at a rate of 0.5 µl/min). A sterile stylet was 196 inserted into each cannula at the completion of the injections. Rats were given an additional 10 197 mL of saline and were placed on a heating pad to recover from surgery. Rats were allowed to 198 recover for one week before being food restricted in preparation for behavioral testing. 199
In vitro electrophysiology 200
Rats (n = 4) were anesthetized with an intraperitoneal injection of a 75-100 mg/kg 201 ketamine and 5-10 mg/kg xylazine solution and were decapitated using a small animal guillotine. 202
Their brains were rapidly extracted and coronal sections containing the BLA (300 µm thick) were 203 obtained using a Leica VT 1000s vibratome while submerged in ice cold sucrose laden 204 oxygenated artificial cerebrospinal fluid (aCSF) containing in (mM): 2 KCl, 1.25 NaH 2PO4, 1 205 MgSO4, 10 D-glucose, 1 CaCl2, 206 sucrose, 25 NaHCO3. Slices were then incubated for 30 206 minutes at 37˚C in aCSF which contained in (mM): 124 NaCl, 2.5 KCl, 1.23 NaH2PO4, 3 MgSO4, 207 10 D-glucose, 1 CaCl2, and 25 NaHCO3. Following this incubation period slices were allowed to 208 equilibrate to room temperature for a minimum of 30 minutes prior to being used for experiments. 209
All solutions were saturated with 95 % O2/ 5 % CO2 to maintain a pH of 7.3. For whole cell patch clamp recordings, slices were transferred to a slice chamber where they were continuously 211 perfused at a rate of 1.5-2ml/min with an aCSF bath solution that contained (in mM): 126 NaCl, 3 212 KCl, 1.2 NaH2PO4, 1.5 MgSO4, 11 D-glucose, 2.4 CaCl2 and 25 NaHCO3. This solution was also 213 saturated with 95 % O2/ 5 % CO2 to maintain a pH of 7.3 and bath temperature was maintained 214 at 30-32˚C. Slices were visualized using infrared differential interference contrast (IR-DIC) 215 microscopy with an Olympus BX51WI upright stereomicroscope, a 12-bit IRC CCD camera 216 (QICAM Fast 1394, QImaging), and a 40x water immersion lens. Patch pipettes were prepared 217 with a Flaming/Brown type pipette puller (Sutter Instrument, P-97) from 1.5 mm/0.8 mm 218 borosilicate glass capillaries (Sutter Instrument) and pulled to a tip resistance of 4-7 MΩ. Whole 219 cell patch clamp recordings were performed using an Axon Mutliclamp 700B amplifier (Molecular 220 Devices, Sunnyvale, CA) and data were collected at 20 kHz, filtered at 2 KHz and recorded with 221 a Digidata 1322A using Clampex v. 9 or 10 (Molecular Devices, Sunnyvale, CA). BLA neurons 222 expressing mCherry were identified using an epifluoresence microscopy XF102-2 filter set 223 (Omega Optical, excitation: 540-580 nm, emission: 615-695 nm). The light source for 224 epifluoresence microscopy was an X-Cite Series 120Q (Lumen Dynamics). Whole cell patch 225 clamping was initiated under IR-DIC using a potassium-based internal solution that contained (in 226 mM): 130 K-gluconate, 10 KCl, 5 NaCl, 2 MgCl 2, 0.1 EGTA, 2 Na2-ATP, 0.3 NaGTP, 10 HEPES 227 and 10 phosphocreatine, pH adjusted to 7.3 using KOH and volume adjusted to 285-300mOsm. 228
Halorhodopsin was activated using 1000 msec light pulses, delivered through the excitation filter 229 in the XF102-2 filter set. Experiments were performed in voltage clamp (at -70 mV), in current 230 clamp (at I=0), or in current clamp during 100-200 pA current injection that was sufficient to drive 231 action potentials. Data were analyzed using custom software written in OriginC (OriginLab, 232 Northampton, MA) by CJF. 233
Behavioral procedures 234
Rats were initially shaped to perform the various components of the decision-making task 236 (e.g., lever pressing; nosepoking to initiate a trial) as described previously (Orsini et al., 2015a) . 237
They then began training in the Risky Decision-Making task (RDT), which was comprised of three 238 28-trial blocks and lasted 56 min in duration [this task design was a modification of a similar design 239 used in our laboratory (Simon et al., 2009; Orsini et al., 2015a) ]. Each 40 s trial ( Figure 1A) began 240 with illumination of the nosepoke and houselight. Upon nosepoking, the nosepoke light was 241 extinguished and either a single lever (forced choice trials) or both levers (free choice trials) 242 extended into the chamber. If rats failed to nosepoke within 10 s, the trial was considered an 243 omission. A press on one lever (left or right; counterbalanced across rats) always yielded a small, 244 "safe" food reward (one food pellet) and a press on the other lever always yielded a large, "risky" 245 food reward (2 food pellets). Delivery of the large reward was accompanied by a variable 246 probability of punishment in the form of a mild footshock (0.25-0.6 mA). The probability of 247 punishment was contingent on a preset probability specific to each block of trials: the probability 248 in the first block was set to 0% and increased across successive blocks (25%, 75%, respectively). 249
The large food reward was delivered irrespective of punishment delivery. Although the levers 250 were counterbalanced across rats, the identities of the small, "safe" lever and large, "risky" lever 251 remained constant for each rat throughout testing. Each block of trials started with eight forced 252 choice trials in which a single lever was extended into the chamber. It is through these forced 253 choice trials that the punishment contingencies for that block were established (four presentations 254 of each lever, randomly presented). During forced choice trials, the probability of punishment 255 following a press for the large reward was dependent upon the outcomes of the other forced 256 choice trial lever presses in that block. For example, in the 25% block, one and only one of the 257 four forced choice trials (randomly selected) resulted in footshock. Similarly, in the 75% block, 258 three and only three of those forced choice trials resulted in footshock. The forced choice trials 259 were followed by 20 free choice trials in which both levers were extended. If rats failed to lever 260 press within 10 s, the house light was extinguished and the trial was counted as an omission. In contrast to the forced choice trials, the probability of punishment in free choice trials was 262 independent, such that the shock probability on each trial was the same regardless of shock 263 delivery on previous trials in that block. During RDT training, shock intensities were adjusted 264 individually for each rat to ensure that there was sufficient parametric space to observe either 265 increases or decreases in risk taking during optogenetic inhibition of BLA. 266
Upon reaching stable baseline performance (see Experimental design and statistical 267
analysis section for description of stability), rats were lightly anesthetized and optic fibers were 268 inserted into the BLA cannulae such that they extended 1 mm beyond the tips of the cannulae. 269
The fibers were cemented into position and dust caps were placed on the fibers to keep them free 270 from debris. In each subsequent RDT session, spring-insulated patch cords fastened to the rotary 271 joint were attached to the implanted fibers in the rat. Rats were trained in this manner until their 272 performance returned to baseline levels (approximately 3 sessions). Upon reaching this criterion, 273 optogenetic manipulations during test sessions began (note that shock intensities were not 274 adjusted between baseline and laser stimulation sessions). Laser stimulation occurred during 275 three different free choice trial phases ( Figure 1B ): 1) deliberation 2) reward outcome and 3) 276 intertrial interval (ITI). The deliberation phase consisted of the time between the nosepoke to 277 trigger lever extension and a lever press, and thus captured the period in which rats were 278 presumably deciding between the two available options. Laser stimulation commenced 0.5 s prior 279 to nosepoke illumination and remained on until a lever press occurred or 5 s elapsed, whichever 280 occurred first. For the reward outcome phase, there were three different stimulation conditions: 281 1) delivery of the small safe reward 2) delivery of the large reward without punishment and 3) 282 delivery of the large reward with punishment. During each outcome condition, laser stimulation 283 began as soon as the rat pressed the lever to yield that outcome and lasted for 5 s. Finally, during 284 the ITI phase, laser stimulation (5 s) occurred 8-15 s after each reward delivery. A randomized, 285 within-subjects design was used such that each rat was tested across multiple stimulation phases.
Because of attrition due to detachment of headcaps, however, not all rats were tested for all 287 phases. In between each stimulation session, rats were tethered and tested in the RDT until their 288 performance in the task across two consecutive sessions was no different from their original 289 baseline prior to any stimulation. If choice performance shifted during these re-baselining 290 sessions, shock intensities were adjusted until performance was comparable to the original 291 baseline. 292
Determination of Shock Intensity Threshold 293
Upon completion of testing in the RDT, rats in the eNpHR3.0 group underwent test 294 sessions in which their shock reactivity was assessed under stimulation and non-stimulation 295 conditions. The procedures were based on those developed by Bonnet and Peterson (1975) to 296 determine the shock thresholds at which specific motor responses were elicited. These test 297 sessions occurred across two days, with each day consisting of two tests: one with laser 298 stimulation and the other without laser stimulation. The order of the test sessions on each day 299 was counterbalanced across the two days. Irrespective of stimulation condition, each test session 300 began with a 2 min baseline period followed by delivery of an unsignaled footshock (0.4 mA, 1 s), 301 which decreased spontaneous motor activity and facilitated detection of motor responses at 302 subsequent low shock intensities. The shock intensity was then set to 0.05 mA and a series of 303 five footshocks (1 s each), each separated by 10 s, was delivered. After each series of footshocks, 304 the shock intensity was increased by 0.025 mA. The increase in shock intensities continued until 305 all motor responses of interest were observed. The shock intensity threshold for a given motor 306 response was determined by the shock intensity at which the given response was elicited by three 307 out of the five footshocks in a series. The motor responses for which shock thresholds were 308 determined consisted of 1) flinch of a paw or a startle response 2) elevation of one or two paws 309
3) rapid movement of three or all paws. For test sessions with laser stimulation, light was delivered 310 bilaterally (560 nm, 8-10mW) using the same procedures and system used during decision-making sessions. To mimic parameters used for laser stimulation during delivery of the large, 312 punished outcome, laser stimulation and footshock were delivered concomitantly, but the laser 313 remained on for an additional 4 s (total stimulation time of 5 s). Even though no light was delivered 314 during test sessions without laser stimulation, rats were still tethered for the duration of the test. 
Experimental design and statistical analyses
Using pilot data collected from several eNpHR3.0 rats, a power analysis was conducted 335 with G*Power software. This analysis indicated that a sample size of at least 4 rats was required 336 to detect significant differences between baseline and stimulation conditions with effect sizes of 337 0.8 and above, assuming an alpha level of 0.05. To account for possible attrition over the course 338 of the experiment, group sizes were larger than that calculated from the power analysis. A total 339 of 35 male Long-Evans rats were used in these experiments. Twenty-six rats received intra-BLA 340 microinjections of the viral vector containing eNpHR3.0, four of which were used for in vitro 341 electrophysiology experiments. Nine rats received intra-BLA microinjections of the viral vector 342 containing mCherry. Within the eNpHR3.0 group, some rats did not undergo every stimulation 343 session due to illness or detachment of headcaps over the course of the experiment. In addition, 344 only a subset of rats (n=6) was used for shock threshold testing. In the control group, there was 345 attrition due to illness or detachment of headcaps, resulting in only four of the initial nine rats 346 completing the stimulation sessions. All 4 rats, however, completed all stimulation conditions. 347
Raw data files were analyzed using a customized analysis template written in Graphic 348 State 4.0 software. This template extracted data for specific task events of interest: numbers of 349 lever presses during forced and free choice trials, latencies to press levers, latencies to nosepoke, was less than 20% in each block for at least two consecutive sessions. Once this criterion was 357 met, stimulation sessions commenced. In between each stimulation session, rats were re-trained 358 in the RDT until their behavior re-stabilized, which was determined using the same criterion. To 359 ensure that the baseline after stimulation was similar to the original baseline (before any 360 stimulation sessions took place), the CV of the means of each block between baseline sessions 361 had to fall below 20%. Upon reaching this criterion, rats were advanced to the next stimulation 362 session. Effects of stimulation (i.e., BLA inhibition) on choice performance were determined using 363 a two-factor repeated measures ANOVA with session condition (i.e., baseline vs. inhibition) and 364 trial block as within-subjects factors. In all analyses, a p-value of 0.05 or less was considered 365 statistically significant. Latencies to nosepoke to trigger lever extension were measured as the 366 interval between the illumination of the nosepoke light and a nosepoke response, excluding trials 367 on which the rat failed to nosepoke altogether (omissions). Using a repeated measures ANOVA, 368 nosepoke response latencies were specifically compared between baseline and deliberation 369 stimulation sessions to determine whether laser stimulation (which was initiated 0.5 sec before 370 nosepoke illumination) affected this aspect of behavior. Effects of BLA inhibition on omissions 371 during free and forced choice trials were analyzed using a paired t-test with session condition as 372 the within-subjects factor. 373
To better understand the effects of BLA inhibition during task phases in which inhibition 374 significantly affected choice behavior, additional analyses were conducted to determine whether 375 optogenetic manipulations altered the degree to which feedback from past trials influenced 376 Shock threshold intensities for the laser stimulation or no laser stimulation sessions were 392 averaged across the two test days. Analysis of shock intensity thresholds was conducted using a 393 two-factor repeated measures ANOVA with stimulation condition (inhibition vs. no inhibition) and 394 motor response as the within-subjects factors. To eliminate the possibility that the order of the 395 test sessions on each day contributed to differences in shock reactivity thresholds, another 396 repeated measures ANOVA was conducted using the same within-subjects factors and also 397 included order of laser stimulation as a between-subjects factor. If either of these parent ANOVAs 398 resulted in main effects or significant interactions, additional repeated measures ANOVA or paired 399 t-tests were performed to determine the source of significance. 400
401
Results 402
In vitro electrophysiology 403
In slices from rats injected with AAV5-CAMKIIα-eHpNR3.0-mCherry, BLA neurons 404 expressing mCherry were identified with epifluorescence microscopy and recorded from using 405 conventional whole-cell recording techniques (see Methods section). mCherry-positive BLA 406 neurons (n=11) had a mean whole cell capacitance of 149 ± 14.9 pF. A subset of these neurons 407 was filled with biocytin, immunolabeled with Alexa-594, and imaged with 2-photon meditated epifluorescence microscopy. Cells examined in this manner were all multipolar and had dense 409 local dendritic branches within the BLA (Figure 2A) Of the 22 rats that received the viral vector containing eNpHR3.0 for optogenetic 424 manipulations, one died during surgery and five were euthanized during training due to detached 425 headcaps. Of the remaining 16 rats, three were excluded due to off-target fiber placements (too 426 ventral; n = 1) or lack of eNpHR3.0 expression in one hemisphere (n = 2). Figure 3A displays the 427 maximum (light gray) and minimum (dark gray) spread of the virus, and Figure 3B depicts the 428 location of optic fiber tips of rats that were included in the final data analysis. A representative 429 placement of a fiber tip in the BLA with eNpHR3.0 expression is shown in Figure 3C . Figure 4A ]. Importantly, 441 this effect was only observed in blocks of trials in which there was a risk of punishment: while 442 there was no effect of inhibition in block 1 [t (11) = -1.27, p = 0.23], BLA inhibition decreased 443 choice of the large, risky outcome in both block 2 [t (11) = 4.51, p < 0.01] and block 3 [t (11) = 444 2.16, p = 0.05]. 445
Additional analyses were performed to determine whether BLA inhibition during 446 deliberation affected the percentage of win-stay or lose-shift trials ( Figure 4B ). There was no effect 447 of inhibition on the percentage of win-stay trials (t (8) = 1.61, p = 0.15), but there was a near 448 significant increase in the percentage of lose-shift trials (t (9) = -1.99, p = 0.08). Note that in the 449 win-stay analysis, three rats were excluded because they either never chose the large, risky 450 outcome or never encountered a trial in which they chose the large, risky outcome and received 451 the large reward without punishment. Similarly, in the lose-shift analysis, two rats were excluded 452 because they never selected the large, risky outcome. This slight increase in lose-shift trials 453 suggests that BLA inhibition slightly increased the likelihood for rats to shift their choice to the 454 small, safe outcome after receiving a large reward accompanied by punishment. Collectively, 455 these results show that BLA inhibition during the period in which rats deliberated between the two 456 available options caused an increase in risk aversion. 457
Finally, there was no effect of BLA inhibition during deliberation on omissions in either the 458 forced choice trials [t (11) = -0.87, p = 0.44] or the free choice trials [t (11) = -0.26, p = 0.80].
Additional analyses were conducted to determine whether inhibition affected rats' latency to 460 nosepoke to trigger lever extension. While there was no main effect of inhibition [F (1, 11) = 0.05, 461 p = 0.82], there was a trend toward a significant inhibition X block interaction [F (2, 22) = 3.10, p 462 = 0.07], with BLA inhibition causing a slight decrease in latency to nosepoke, particularly in block 463 3 [mean of 1.87 (±0.24) s for baseline; mean of 1.48 (± 0.15) s for stimulation]. Note, however, 464 that because light onset commenced 0.5 s before the nosepoke was illuminated to signal the 465 beginning of a trial, BLA inhibition should have been maximal prior to the start of the deliberation 466 period. 467
468

BLA inhibition during delivery of the small, safe outcome 469
Optogenetic inhibition of the BLA during delivery of the small, safe outcome (n = 10) had 470 no effect on choice of the large, risky outcome [inhibition, F (1, 9) = 0.09, p = 0.77; inhibition X 471 block, F (2, 18) = 1.73, p = 0.21; Figure 5A ]. Additionally, inhibition had no effect on omissions 472 (Table 1) Similarly, there was no effect of BLA inhibition during the large, unpunished outcome (n = 478 9) on choice behavior [inhibition, F (1, 8) = 0.45, p = 0.52; inhibition X block, F (2, 16) = 0.30, p 479 =0.74; Figure 5B ]. There were also no effects of inhibition on omissions (Table 1) Figure 6A ]. It is important to note that this analysis only used choice behavior 489 in the 25% and 75% blocks from baseline and stimulation sessions, as they were the only blocks 490 in which BLA inhibition could occur. 491
Given the significant effects of BLA inhibition during this phase of the task, additional 492 analyses were performed to determine how this manipulation affected the percentage of win-stay 493 or lose-shift trials ( Figure 6B ). There was no effect of BLA inhibition on the percentage of win/stay 494 trials [t (9) = -0.44, p = 0.67]; however, there was a significant decrease in the percentage of 495 lose/shift trials [t (9) = 3.02, p = 0.01] compared to baseline. Thus, BLA inhibition during delivery 496 of the large, punished outcome caused rats to increase the likelihood of choosing the large, risky 497 outcome, despite having been punished for this choice on the preceding trial. 498
Lastly, there were no effects of BLA inhibition on omissions (Table 1) during free choice 499 trials [t (9) = 0.09, p = 0.93], although inhibition did cause a significant decrease in omissions 500 during forced choice trials compared to baseline conditions [t (9) = 2.56, p = 0.03]. 501 502 BLA inhibition during shock threshold testing 503
Rather than affecting processes related to risk taking per se, the effects of BLA inhibition 504 during delivery of the large, punished outcome may have been due to an inhibition-induced 505 decrease in shock sensitivity. To address this, a subset of rats (n = 6) was tested in a behavioral 506 assay that evaluates the thresholds at which selective motor responses (as described in the 507
Methods section) are elicited by shock delivery. These thresholds were obtained under stimulation 508 and no stimulation (inhibition vs. no inhibition, respectively) conditions ( Figure 6C) . A two-factor 509 repeated measures ANOVA revealed neither a main effect of inhibition [F (1, 5) = 4.00, p = 0.10] 510 nor an inhibition X motor response interaction [F (2, 10) = 0.04, p = 0.96]. Thus, the increase in risky choice during sessions in which BLA inhibition occurred during delivery of the large, 512 punished outcome cannot be accounted for by a decrease in footshock sensitivity. 513
514
BLA inhibition during ITIs 515
Optogenetic inhibition of the BLA during the ITI (n = 13) had no effect on choice of the 516 large, risky outcome [inhibition, F (1, 12) = 0.01, p = 0.91; inhibition X block, F (2, 24) = 0.02, p = 517 0.98; Figure 5C ]. Similarly, BLA inhibition during ITIs did not affect omissions during forced choice 518 trials [t (12) = 0.3, p = 0.77], but caused a near significant increase in omissions during free choice 519 trials [t (12) = -2.04, p = 0.06]. 520 521
Optogenetic BLA stimulation during decision making in control rats 522
To ensure that the effects of BLA inhibition were not due to light delivery alone, another 523 group of rats received intra-BLA microinjections of a vector carrying mCherry alone and were then 524 trained in the RDT. Because BLA inhibition only altered choice behavior during deliberation and 525 delivery of the large, punished outcome in eNpHR3.0 rats, control rats only received stimulation 526 during these two phases (in separate sessions, in a randomized order across rats). 527 528 BLA stimulation during deliberation 529 BLA stimulation during deliberation (n = 4) had no effect on choice of the large, risky 530 outcome compared to baseline conditions [stimulation, F (1, 3) = 1.00, p = 0.39; stimulation X 531 block, F (2, 6) = 1.00, p = 0.42; Figure 7A ]. There was no main effect of BLA stimulation on latency 532 to nosepoke to initiate lever extension [F (1, 3) = 2.33, p = 0.23; Table 1 ]; however, it appeared 533 that under stimulation conditions, latency to nosepoke did increase across the session [F (2, 6) = 534 7.70, p = 0.02]. While there was a trend toward a significant effect of stimulation on omissions 535 (Table 1) during forced choice trials [t (3) = -2.82, p = 0.07], this was due to the fact that there 536 were fewer omissions under stimulation compared to baseline conditions. There were no effects of BLA stimulation on omissions during free choice trials [t (3) = 1.00, p = 0.39]. Collectively, these 538 results indicate that laser stimulation of BLA alone during deliberation did not affect risky decision 539 making in control rats. 540
541
BLA stimulation during delivery of the large, punished outcome 542
There was also no effect of BLA stimulation during delivery of the large, punished outcome 543 (n = 4) on choice of the large, risky outcome [stimulation, F (1, 3) = 1.00, p = 0.39; stimulation X 544 block, F (2, 6) = 1.0, p = 0.42; Figure 7B ]. There was a trend toward a significant effect of 545 stimulation on omissions (Table 1) during forced choice trials [t (3) = -2.82, p = 0.07]; however, 546 this again appeared to be due to fewer omissions under stimulation compared to baseline 547 conditions. There were no differences in omissions during free choice trials between stimulation 548 and baseline conditions [t (3) = 1.67, p = 0.19]. Hence, laser stimulation of BLA alone during 549 delivery of the large, punished outcome had no effect on risky decision making in control rats. BLA inhibition during delivery of the large, punished outcome had the opposite effect (increased 559 risky choice). These effects were specific to the task phase in which inhibition occurred because 560 BLA inhibition had no effect on choice behavior during delivery of the small, safe outcome, the 561 large, unpunished outcome, or the ITI. Further, there were no effects of light delivery into the BLA during deliberation or delivery of the large, punished outcome in control rats (in the absence of 563 eNpHR3.0). 564
The overall finding that BLA manipulation alters choice performance during risky decision 565 making is consistent with previous studies implicating this region in cost/benefit decision making. 566
In a risky decision making task involving choices between a small, certain food reward and a 567 large, probabilistic food reward, pharmacological inactivation of BLA decreased choice of the 568 large, probabilistic reward, but only at probabilities at which it was more profitable to choose this To circumvent this issue, the current study employed optogenetics to selectively inhibit the 578 BLA during distinct phases of the decision-making process. In contrast to effects of permanent 579 BLA lesions (Orsini et al. 2015a ), optogenetic inhibition caused both an increase and decrease in 580 risky choice depending on the timepoint at which inhibition occurred. These results suggest that 581 the contribution of the BLA to risky choice is not uniform, but instead that it may function in different 582 capacities even over the course of a few seconds of a decision-making trial. During deliberation, 583 various sources of information must be assimilated to bias behavior toward a specific choice. In 584 particular, information about the anticipated rewarding aspects of each potential outcome must 585 be integrated and weighed against the negative/adverse aspects of those outcomes. BLA 586 inhibition during this period interfered with this integrative process such that choices were more 587 strongly biased by punishment-related information. One possibility is that this is due to a loss of reward magnitude information, although this seems unlikely given that choice behavior was intact 589 in the first block of trials (in which there was no risk of punishment). Alternatively, and consistent 590 with the slight increase in lose-shift trials, BLA inhibition may have augmented the salience of the 591 punishment associated with the large reward. This also seems unlikely, however, given that 592 lesions and pharmacological inactivation of the BLA reduce fear expression in other contexts 593 (Helmstetter and Bellgowan, 1994; Maren et al., 1996) . A final, and more likely possibility is that 594 BLA inhibition during deliberation may have attenuated the incentive salience of anticipated 595 outcomes and, consequently, the ability to bias action selection toward more salient rewards. 596
Hence, the BLA may be important for tagging available outcomes based on their incentive 597 salience (i.e., to favor larger, albeit risker, outcomes). In the absence of an intact BLA, the 598 punishment history and/or aversive properties of these outcomes prevail and drive choice 599 behavior. 600
In contrast, the increase in risk-taking following BLA inhibition during delivery of the large, 601 punished outcome suggests that the BLA is engaged in a manner different from that during 602 deliberation. Incorporating feedback about outcomes of past choices to guide future choice is a 603 critical aspect of adaptive decision making. The BLA has long been implicated in encoding and 604 representing aversive properties of stimuli in Pavlovian and instrumental learning tasks (Wassum 605 and Izquierdo, 2015). Thus, inhibition during delivery of the large, punished outcome may have 606 prevented the BLA from encoding the punishing aspects of this outcome and therefore impaired 607 the ability to use this information as feedback to adjust future choice behavior. This would result 608 in choice performance being driven by rewarding properties of this outcome, irrespective of 609 whether its delivery was accompanied by footshock. This is supported by the significant decrease 610 in lose-shift trials such that rats continued to choose the large, risky outcome despite having been 611 punished on the preceding trial. Importantly, the effects of BLA inhibition during this phase were 612 not due to alterations in shock sensitivity, as there were no changes in thresholds at which shock-613 induced motor responses were elicited. This is consistent with previous work showing that BLA lesions do not affect discrimination between punished and unpunished rewards of the same 615 magnitude (Orsini et al., 2015a) and when considered together, demonstrates that the BLA is not 616 necessary for encoding shock alone. Collectively, these data suggest that when a rewarding 617 outcome is accompanied by an adverse consequence, the BLA may be responsible for encoding 618 the negative aspects of that outcome that can then be used as feedback during future deliberation. 619
The idea that the BLA functions in a heterogeneous manner during risky decision making 620 Rats must nosepoke for the extension of either one lever (forced choice trial) or both levers (free 670 choice trial). A press on one lever yields a small safe reward and a press on the other yields a 
